Development of a peptide-based therapeutic agent against non-small cell lung cancer caused by EML4-ALK targeting the substrate recognition site

Hiroyuki Hara

11:20 AM - 11:30 AM

[1T02m-02] Development of a peptide-based therapeutic agent against non-small cell lung cancer caused by EML4-ALK targeting the substrate recognition site

^○Hiroyuki Hara¹, Miho Takahashi¹, Norihito Shibata², Mikihiko Naitou², Kiyotaka Nishikawa¹ (1.Dept. of Mol. Life Sci., Grad. School of Life and Med. Sci., Doshisha Univ., 2.Div. of Mol. Target and Gene Therapy Prod., NIHS)

キーテクノロジー：ペプチドシートスクリーニング

非小細胞肺がん、EML4-ALK、キナーゼ基質認識部位、ペプチド創薬

cygd2002@mail4.doshisha.ac.jp

Contents of this site has moved to the member page of The Japanese Biochemical Society: https://member.jbsoc.or.jp/mypage/
You can access the abstracts without credentials by accessing them via the member page.

You need the membership number and password to access the member page. Please contact the journal office for any inquiries.

Journal Office Contact Information:
E-mail:jbs-ho@jbsoc.or.jp
Tel:03(3815)1913 Fax:03(3815)1934

The 92nd Annual Meeting of JBS

[1T02m-02] Development of a peptide-based therapeutic agent against non-small cell lung cancer caused by EML4-ALK targeting the substrate recognition site

Password